PRINCETON, N.J., July 8 /PRNewswire/ -- BullMarket.com (http://www.bullmarket.com), an online investment newsletter focused on long-term growth and income-generating stocks, has provided subscribers with detailed coverage of Healthcare IT stocks, including Cerner (Nasdaq: CERN), athenahealth (Nasdaq: ATHN), Allscripts-Misys (Nasdaq: MDRX), Eclipsys (Nasdaq: ECLP), Quality Systems (Nasdaq: QSII), and McKesson (NYSE: MCK).
All paid and trial subscribers to BullMarket.com can now receive immediate access to the newsletter's exclusive daily reports. As a subscriber, you'll also gain access to our Recommended List of stocks, which outperformed the S&P 500 by 15% in 2008.
Start your 14-day free trial today:
In its daily report, BullMarket.com wrote: "In his investor presentations, athenahealth Chairman and CEO Jonathan Bush notes that the Obama Administration through its stimulus package is basically pushing a pay-for-performance model as a way of encouraging doctors to adopt EHR systems. The government's approach, he said, requires doctors to communicate better with patients, something he said they typically don't do very well after an office visit."
BullMarket.com looked at the following topics, among others:
-- Is now the time to buy healthcare IT stocks, or should investors wait for a pullback?
-- What recent deals look to be good ones for Allscripts-Misys?
-- How is athenahealth set to benefit from the HITECH Act portion of the economic stimulus?
-- Which healthcare IT stock is BullMarket.com's favorite and why?
Launched in 1997, BullMarket.com has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The BullMarket.com Recommended List includes about 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. BullMarket.com is one of the oldest continuously published investment newsletters online, and its Recommended List has consistently outperformed the major market indices.
NOTE: This release was published by Indie Research Advisors, LLC, a registered investment advisor with CRD #131926. Interested parties may visit adviserinfo.sec.gov for additional information. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contact: Marcie Martin, Bull Market Report, +1-888-278-5515
|SOURCE Indie Research Advisors, LLC|
Copyright©2009 PR Newswire.
All rights reserved